Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
Do you have experience combining tocilizumab with mycophenolate in patients with scleroderma lung disease and inflammatory arthritis?
Related Questions
When do you recommend initiation of targeted therapies in active RA with history of malignancy?
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
How do you approach the timing of DMARD initiation in patients with active RA who are on treatment for latent TB?
How would you manage a patient with erosive seronegative rheumatoid arthritis with IgG and IgM deficiency?
Do you combine methotrexate and leflunomide for the treatment of RA?
What is your approach for cancer screening for elderly onset RA?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
